Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

VanEck Pharmaceutical ETF (NQ:PPH)

101.12 +0.19 (+0.19%)
Streaming Delayed Price Updated: 2:30 PM EDT, Mar 24, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 64,589
Open 100.59
Bid (Size) 101.10 (200)
Ask (Size) 101.14 (100)
Prev. Close 100.93
Today's Range 100.26 - 101.16
52wk Range 77.67 - 112.58
Shares Outstanding N/A
Dividend Yield 1.23%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Novo Nordisk-Hims Deal Turns Wall Street Bullish — BMO Sees Relief From Commercial Headwinds, BofA Upgrades HIMS Stock ↗
BMO Capital maintained its ‘Market Perform’ rating for Novo Nordisk, with a price target of $45, implying an upside of more than 13% from NVO stock’s closing price on Monday. 
Via Stocktwits
Topics Intellectual Property Lawsuit
News headline image
HIMS Stock Soars After Novo Nordisk Drops Patent Infringement Lawsuit, Opens Access To Ozempic, Wegovy ↗
Hims & Hers also stated that it will no longer advertise compounded GLP-1 offerings on its platform or in its marketing. 
Via Stocktwits
Topics Intellectual Property Lawsuit

Performance

YTD
-2.5%
-2.5%
1 Month
-8.8%
-8.8%
3 Month
-1.8%
-1.8%
6 Month
+14.2%
+14.2%
1 Year
+9.2%
+9.2%

More News

Read More
News headline image
FDA Vaccine Chief Vinay Prasad To Exit Agency In April: Report ↗
Via Stocktwits
News headline image
Novo, Vivtex Ink $2.1 Billion Deal To Develop Oral Medicines For Obesity And Diabetes ↗
Via Stocktwits
Novo Looks To Ireland To Scale Production Of Wegovy Pill: Report ↗
Via Stocktwits
KZIA Stock Is Rising Today — What Does Its Data For Nuclear PD-L1 Degrader Show? ↗
Via Stocktwits
Why Did NRXP Stock Surge 21% Pre-Market Today? ↗
Via Stocktwits
News headline image
Why Did GERN Stock Tumble 10% Pre-Market Today? ↗
Via Stocktwits
Topics Artificial Intelligence
News headline image
Novo Nordisk To Cut Ozempic, Wegovy Prices By Up To 50%: Report ↗
Via Stocktwits
Topics Artificial Intelligence
News headline image
NVO Stock Continues To Decline Pre-Market After Monday’s Crash Amid CagriSema Setback – But Tuesday Brings Some Hope From China ↗
Via Stocktwits
News headline image
Merck Is Reportedly Splitting Its Pharma Division As Keytruda Patent Nears 2028 Expiry ↗
Via Stocktwits
Topics Intellectual Property
News headline image
Why Is NVO Stock Falling Pre-Market Today? ↗
Via Stocktwits
Topics Government
News headline image
FDA Says Novo's Wegovy Pill TV Advertisement Is Misleading: NVO Stock Pares Gains ↗
Via Stocktwits
Topics Lawsuit
News headline image
Why Did IINN Stock Surge 28% In Pre-Market Today? ↗
Via Stocktwits
News headline image
Novo Nordisk Sues Hims & Hers Over Compounded Wegovy, Calls For Permanent Sales Ban: HIMS Stock Tanks ↗
Via Stocktwits
Topics Intellectual Property Lawsuit
News headline image
US-UK Near Landmark Zero-Tariffs Pharma Deal, Announcement Expected Soon: Report ↗
Via Stocktwits
Topics World Trade
News headline image
Hedge Funds Snap Up Eli Lilly, United Healthcare, And More, Putting Healthcare ETFs Back In The Spotlight ↗
Via Benzinga
Topics ETFs
News headline image
Eli Lilly Supremacy: How One Stock Is Dictating Performance Across Pharma ETFs ↗
Via Benzinga
Topics ETFs
News headline image
Eli Lilly CEO Slams PBM 'Rent Taking', Says They Drove Insulin List Prices To $275: 'We Can Disintermediate Them Easily' ↗
Via Benzinga
News headline image
Eli Lilly Extends Lead In $150B Obesity Drug Race As Novo, Pfizer Clash — Here's How ETFs Stand To Gain ↗
Via Benzinga
Topics ETFs
News headline image
Trump's Weight-Loss Drug Push May Put These ETFs On A Diet ↗
Via Benzinga
Topics ETFs Government
News headline image
Drug Stocks Just Had Their Best Week in 2 Decades. Should You Invest? ↗
Via The Motley Fool
Topics ETFs Government World Trade
News headline image
Pharma ETFs In A Tariff Storm: How Investors Can Hedge Risk ↗
Via Benzinga
Topics ETFs
News headline image
Trump's 100% Drug Tariff Will Hit Americans, Economist Says Buyers 'Eat The Cost,' Not Foreign Firms ↗
Via Benzinga
Topics Government World Trade
News headline image
Pharma Tariffs Back In Spotlight On New Trump Threat ↗
Via Investor's Business Daily
Topics ETFs Government World Trade

Frequently Asked Questions

Is VanEck Pharmaceutical ETF publicly traded?
Yes, VanEck Pharmaceutical ETF is publicly traded.
What exchange does VanEck Pharmaceutical ETF trade on?
VanEck Pharmaceutical ETF trades on the Nasdaq Stock Market
What is the ticker symbol for VanEck Pharmaceutical ETF?
The ticker symbol for VanEck Pharmaceutical ETF is PPH on the Nasdaq Stock Market
What is the current price of VanEck Pharmaceutical ETF?
The current price of VanEck Pharmaceutical ETF is 101.12
When was VanEck Pharmaceutical ETF last traded?
The last trade of VanEck Pharmaceutical ETF was at 03/24/26 02:30 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

© Copyright 2015, Penticton Herald, Penticton, BC. Powered by BLOX Content Management System from TownNews.com.